Russia files to register its Sputnik V coronavirus vaccine in Europe

Spread the love

Russia’s sovereign wealth fund RDIF has filed for registration of Sputnik V in the European Union and expects it to be reviewed in February, the official account promoting the COVID-19 vaccine tweeted on Wednesday, moving it closer to wider adoption across the globe. The vaccine has already been approved in Argentina, Belarus, Serbia and other…

At a glance:

Spread the love

Russia’s sovereign wealth fund RDIF has filed for registration of Sputnik V in the European Union and expects it to be reviewed in February, the official account promoting the COVID-19 vaccine tweeted on Wednesday, moving it closer to wider adoption across the globe.

The vaccine has already been approved in Argentina, Belarus, Serbia and other countries.

The Sputnik V and European Medical Agency (EMA) teams held a scientific review of the vaccine on Tuesday, the Sputnik V account said, adding the EMA will take a decision on the authorization of the vaccine based on the reviews. (https://bit.ly/39OQZDR)

The country would submit a formal application to the European Union in February for approval of its Sputnik V coronavirus vaccine, RDIF chief Kirill Dmitriev had said in an interview at the Reuters Next conference last week.

(Catch all the Business News, Breaking News Events and Latest News Updates on The Economic Times.)

Download The Economic Times News App to get Daily Market Updates & Live Business News.

Entrepreneur Podcast

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.